Abstract
In this work, we have developed a Sanger's reagent-based photocage, LNDA-NBD-Sanger, which releases the caged COX-2 inhibitor, lenalidomide (LNDA), under 400 nm UV irradiation while producing a fluorescent signal from the activated nitrobenzoxadiazole (NBD) derivative, realizing the monitoring of LNDA release in cancer cells and light-controlled anti-cancer therapy.
Original language | English |
---|---|
Pages (from-to) | 6518-6521 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 61 |
Issue number | 35 |
DOIs | |
State | Published - 28 Mar 2025 |